Posts With Tag Collaboration Agreements

Showing 1 - 2 of 2 Posts

IDEAYA Biosciences FY 2024 Financial Report: Growth Amid Rising Losses

$IDYA

•

Form 10-K

•

2025-02-18

Last updated: 2 months ago

IDEAYA Biosciences FY 2024 Financial Report: Growth Amid Rising Losses

Explore IDEAYA Biosciences' FY 2024 financial report highlighting revenue drop, R&D surge, and strategic partnerships. Recommended investor stance: Hold.

Oncology Biotech R&D Investment Clinical Trials Collaboration Agreements

Arrowhead Pharmaceuticals Q4 2024 Financial Report: Losses & Promising Collaborations

$ARWR

•

Form 10-Q

•

2025-02-10

Last updated: 3 months ago

Arrowhead Pharmaceuticals Q4 2024 Financial Report: Losses & Promising Collaborations

Explore Arrowhead Pharmaceuticals' Q4 2024 report highlighting a $173.1M net loss, $578.3M in securities, and strategic partnerships worth up to $14.1B. Investment recommendation: Hold.

Biopharmaceuticals RNA interference Clinical trials Investment analysis Collaboration agreements